Eat by the clock, not by hunger Because Wegovy can lower hunger, relying on appetite to guide eating can lead to inadequate intake
Benefits Semaglutide and liraglutide share a few common benefits, such as: Both drugs promote blood sugar control in patients with type 2 diabetes Semaglutide (Wegovy) and liraglutide (Saxenda) help reduce body weight in obese and overweight patients Both drugs have potential cardiovascular benefits and reduce the risk of heart attack, stroke, and cardiovascular death Side effects As semaglutide and liraglutide belong to the same class of drugs (GLP-1 receptor agonist), they have common side effects such as nausea, vomiting, diarrhea, constipation, stomach pain, injection site reaction, and pancreatitis
Medications developed by pharmaceutical companies like Eli Lilly and Company offer new hope in the treatment of obese individuals, helping them lose weight and manage their condition effectively
Improvements in bloating, constipation patterns , and overall digestive comfort may correlate with broader immune function changes, though this connection has not been formally studied in clinical trials